Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
02/2010
02/09/2010CA2389688C A method of microencapsulation
02/09/2010CA2370714C Bacterial ghosts as carrier and targeting vehicles
02/09/2010CA2349715C Electrotransport device including a compatible antimicrobial agent
02/09/2010CA2338546C Particle-forming compositions containing fused pyrrolocarbazoles
02/09/2010CA2334222C Insulin supplemented infant formula
02/09/2010CA2287469C Interactive system for presenting and eliminating substances
02/09/2010CA2286614C Plant extracts for the treatment of increased bone resorption
02/09/2010CA2235810C Senescent cell-derived inhibitors of dna synthesis
02/09/2010CA2218369C Transdermal electrotransport delivery of fentanyl and sufentanil
02/08/2010CA2672181A1 Adhesive patch for protecting and treating viral cutaneous lesions
02/04/2010WO2010014895A2 Nanoparticle compositions for nucleic acids delivery system
02/04/2010WO2010014827A2 Formulations containing large-size carrier particles for dry powder inhalation aerosols
02/04/2010WO2010014766A1 Low dosage forms of risedronate or its salts
02/04/2010WO2010014765A1 Low dosage forms of risedronate or its salts
02/04/2010WO2010014658A1 Thermochemical ablation system using heat from delivery of electrophiles
02/04/2010WO2010014541A2 Compositions and methods for treatment of hypercholesterolemia
02/04/2010WO2010014502A1 Functionally coated breakable tablets
02/04/2010WO2010014176A2 Preparation method of biodegradable micro-particles containing drugs
02/04/2010WO2010014172A2 Delivery particle
02/04/2010WO2010014081A1 Particle compositions with a pre-selected cell internalization mode
02/04/2010WO2010014015A1 Tablet manufacturing method
02/04/2010WO2010014011A1 Microencapsulate and process for the manufacture thereof
02/04/2010WO2010013836A1 Active targeting type polymeric micelle carrying drug enclosed therein and medicinal composition
02/04/2010WO2010013823A2 Pharmaceutical composition
02/04/2010WO2010013815A1 Composition for inhibiting expression of target gene
02/04/2010WO2010013799A1 Pressure-sensitive adhesive sheet to be stuck to the skin
02/04/2010WO2010013656A1 Packaging material
02/04/2010WO2010013640A1 Potentiator of therapeutic efficacy on infectious disease
02/04/2010WO2010013601A1 Microneedle device and method for increasing the response of japanese encephalitis virus antigen with the microneedle device
02/04/2010WO2010013555A1 Novel lipid dipeptide and gel
02/04/2010WO2010013551A1 Preparation for oral administration comprising water-extracted chondroitin sulfate and quercetin glycoside
02/04/2010WO2010013350A1 S/o type transdermal immunizing agent
02/04/2010WO2010013250A2 Microcapsules comprising active ingredients and a metal oxide shell, a method for their preparation and uses thereof
02/04/2010WO2010013224A2 Curcumin nanoparticles and methods of producing the same
02/04/2010WO2010013035A1 Method and product
02/04/2010WO2010013020A2 Sleeve for transdermal patches
02/04/2010WO2010012940A2 Microparticulate oral drug form useful for the modified release of nanoparticles
02/04/2010WO2010012816A1 Nanoparticles - external field effects
02/04/2010WO2010012507A1 Biologically active silicic acid
02/04/2010WO2010012490A1 Quetiapine composition
02/04/2010WO2010012482A1 Ropinirole composition
02/04/2010WO2010012437A1 Pharmaceutical formulation comprising a cb1-receptor compound in a solid solution and/or solid dispersion
02/04/2010WO2010012408A2 Microemulsion
02/04/2010WO2010012248A1 Telmisartan tablets
02/04/2010WO2010012131A1 The usage of medicinal composition containing oil of zedoary turmeric in manufacture of medicaments
02/04/2010WO2010012127A1 Use of a traditional chinese medicinal composition for preparing medicine for promoting bone marrow-derived mesenchymal stem cell survival in vivo and cardiac muscle differentiation
02/04/2010WO2010012025A1 Amnion epithelial cells for the treatment of degenerative disc disease
02/04/2010WO2009150371A3 Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors
02/04/2010WO2009150257A3 Compositions for treating rosacea comprising chitosan and a dicarboxylic acid
02/04/2010WO2009148583A3 Method for improvement of octreotide bioavailability
02/04/2010WO2009137611A9 Treatment of pulmonary fungal infection with voriconazole via inhalation
02/04/2010WO2009117242A3 Aqueous pharmaceutical compositions containing borate-polyol complexes
02/04/2010WO2009115178A3 Gingival wafer
02/04/2010WO2009108760A8 Dendritic macroporous hydrogels prepared by crystal templating
02/04/2010WO2009073630A3 Methods and compositons for enhancing the viability of microneedle pores
02/04/2010WO2009010494A3 Micro-particles, blood-substitute and method for forming same
02/04/2010WO2009004039A3 Hard gelatin capsule formulation comprising a pumpkin product
02/04/2010WO2008132710A3 Pharmaceutical nimodipine compositions
02/04/2010WO2008081462A3 Treating lice with gaseous compounds in an airtight space
02/04/2010US20100030199 Configurations And Methods For Power Generation In LNG Regasification Terminals
02/04/2010US20100030198 Drug delivery platform utilizing hydrogel pumping mechanism
02/04/2010US20100030129 Dermal patch
02/04/2010US20100029897 Anion-binding polymers and uses thereof
02/04/2010US20100029760 Obesity and Metabolic Syndrome Treatment with Tanshinone Derivatives Which Increase Metabolic Activity
02/04/2010US20100029755 P-Glycoprotein inhibitor comprising octilonium bromide as an effective ingredient
02/04/2010US20100029550 Organic compounds
02/04/2010US20100029549 Situ self-setting mineral-polymer hybrid materials, composition and use thereof
02/04/2010US20100029545 Boronic acid-containing block copolymers for controlled drug delivery
02/04/2010US20100028454 Preparation method for biodegradable micro-particles containing drugs
02/04/2010US20100028453 Multi -functional nanoparticles partially-deposited with gold film
02/04/2010US20100028452 Delivery system for active components as part of an edible composition having preselected tensile strength
02/04/2010US20100028451 Silk microspheres for encapsulation and controlled release
02/04/2010US20100028450 Tolerogenic biodegradable artificial antigen presenting system
02/04/2010US20100028449 Fermented milk product and use thereof
02/04/2010US20100028448 Immunogenic compositions and methods of use
02/04/2010US20100028447 Intranasal, Buccal, And Sublingual Administration Of Metanicotine Analogs
02/04/2010US20100028446 Transport of drugs via the blood-brain barrier by means of apolipoproteins
02/04/2010US20100028445 Polymer
02/04/2010US20100028444 Use of water-dispersible carotenoid nanoparticles as taste modulators, taste modulators containing water-dispersible carotenoid nanoparticles, and, method for taste modulation
02/04/2010US20100028443 Compositions and methods for treating inflammation
02/04/2010US20100028442 Methods of therapeutic treatment of eyes
02/04/2010US20100028441 Compositions and methods for treating multiple sclerosis
02/04/2010US20100028440 Drying of drug-containing particles
02/04/2010US20100028439 Nanoparticulate stabilized anti-hypertensive compositions
02/04/2010US20100028438 Hyaluronic Acid-Based Gels Including Lidocaine
02/04/2010US20100028437 Hyaluronic Acid-Based Gels Including Lidocaine
02/04/2010US20100028436 Polymer matrix, uses thereof and a method of manufacturing the same
02/04/2010US20100028435 Injectable hydrogel with an enhanced remanence and with an enhanced ability to create volume
02/04/2010US20100028434 Temperature controlled and pH dependent self gelling biopolymeric aqueous solution
02/04/2010US20100028433 Immunogenic compositions comprising nanoemulsion and hepatitis b virus immunogen and methods of using the same
02/04/2010US20100028432 Formulations of active principles incorporated in slns suitable for transdermal administration
02/04/2010US20100028431 Compositions and methods for therapeutic use
02/04/2010US20100028430 Material and manufacturing method of bioactive protein-calcium phosphate composite
02/04/2010US20100028429 Salts of potassium atp channel openers and uses thereof
02/04/2010US20100028428 Fumarate salt of (alpha s, beta r)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol
02/04/2010US20100028427 Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
02/04/2010US20100028426 Time-specific delayed/pulsatile release dosage forms.
02/04/2010US20100028425 Pharmaceutical composition of atovaquone
02/04/2010US20100028424 Multilayer thin film comprising two or more adjacent layers of oppositely charged polyelectrolytes and encapsulated antigenic peptides; vaccine development for hepatitis B virus, HIV, bacteria, parasites, and viruses
02/04/2010US20100028423 multilayer film comprising layers of polyelectrolytes; antigenic polypeptide comprising surface adsorption regions covalently linked to antigenic determinant regions; parasite antigen; eliciting an immune response in a vertebrate organism; vaccines drug delivery device
1 ... 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 ... 2991